BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21071556)

  • 61. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
    Evans T; Smith MM; Tanner LI; Harden TK
    Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dosage-dependent regulation of cell proliferation and adhesion through dual β2-adrenergic receptor/cAMP signals.
    Bruzzone A; Saulière A; Finana F; Sénard JM; Lüthy I; Galés C
    FASEB J; 2014 Mar; 28(3):1342-54. PubMed ID: 24308976
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Functional alpha1- and beta2-adrenergic receptors in human osteoblasts.
    Huang HH; Brennan TC; Muir MM; Mason RS
    J Cell Physiol; 2009 Jul; 220(1):267-75. PubMed ID: 19334040
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nitric oxide modulates beta(2)-adrenergic receptor palmitoylation and signaling.
    Adam L; Bouvier M; Jones TL
    J Biol Chem; 1999 Sep; 274(37):26337-43. PubMed ID: 10473590
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of agonist intrinsic activity on the desensitisation of beta2-adrenoceptor-mediated responses in mast cells.
    Scola AM; Chong LK; Chess-Williams R; Peachell PT
    Br J Pharmacol; 2004 Sep; 143(1):71-80. PubMed ID: 15289287
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pro-inflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent.
    Grisanti LA; Evanson J; Marchus E; Jorissen H; Woster AP; DeKrey W; Sauter ER; Combs CK; Porter JE
    Mol Immunol; 2010 Mar; 47(6):1244-54. PubMed ID: 20116105
    [TBL] [Abstract][Full Text] [Related]  

  • 67. H1-histamine receptors on human astrocytoma cells.
    Nakahata N; Martin MW; Hughes AR; Hepler JR; Harden TK
    Mol Pharmacol; 1986 Feb; 29(2):188-95. PubMed ID: 2419744
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
    Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
    Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular analysis of beta-adrenergic receptor subtypes in rat collecting duct: effects on cell cAMP and Ca2+ levels.
    Mandon B; Siga E; Champigneulle A; Imbert-Teboul M; Elalouf JM
    Am J Physiol; 1995 Jun; 268(6 Pt 2):F1070-80. PubMed ID: 7611448
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nitric oxide signalling by selective beta(2)-adrenoceptor stimulation prevents ACh-induced inhibition of beta(2)-stimulated Ca(2+) current in cat atrial myocytes.
    Dedkova EN; Wang YG; Blatter LA; Lipsius SL
    J Physiol; 2002 Aug; 542(Pt 3):711-23. PubMed ID: 12154173
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential signaling of the endogenous agonists at the beta2-adrenergic receptor.
    Reiner S; Ambrosio M; Hoffmann C; Lohse MJ
    J Biol Chem; 2010 Nov; 285(46):36188-98. PubMed ID: 20837485
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
    Faisy C; Risse PA; Naline E; Guerot E; Fagon JY; Devillier P; Advenier C
    Life Sci; 2006 Oct; 79(20):1929-35. PubMed ID: 16820175
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling.
    Nikolaev VO; Bünemann M; Schmitteckert E; Lohse MJ; Engelhardt S
    Circ Res; 2006 Nov; 99(10):1084-91. PubMed ID: 17038640
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antioxidant defense against antidepressants in C6 and 1321N1 cells.
    Slamon ND; Pentreath VW
    Chem Biol Interact; 2000 Jul; 127(3):181-99. PubMed ID: 10967317
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protein kinase C activators sensitize cyclic AMP accumulation by intact 1321N1 human astrocytoma cells.
    Johnson RA; Toews ML
    Mol Pharmacol; 1990 Feb; 37(2):296-303. PubMed ID: 1689454
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.
    Plazinska A; Plazinski W; Jozwiak K
    Eur Biophys J; 2015 Apr; 44(3):149-63. PubMed ID: 25726162
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alpha-adrenergic inhibition of proliferation in HepG2 cells stably transfected with the alpha1B-adrenergic receptor through a p42MAPkinase/p21Cip1/WAF1-dependent pathway.
    Auer KL; Spector MS; Tombes RM; Seth P; Fisher PB; Gao B; Dent P; Kunos G
    FEBS Lett; 1998 Sep; 436(1):131-8. PubMed ID: 9771908
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Desensitization of beta2-adrenoceptor and hypersensitization to phosphodiesterase inhibitors elicited by beta2-agonists in guinea pig eosinophils.
    Mio M; Kirino Y; Kamei C
    J Allergy Clin Immunol; 2000 Nov; 106(5):896-903. PubMed ID: 11080712
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.
    Reinartz MT; Kälble S; Wainer IW; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):517-24. PubMed ID: 25637582
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY; Bergsbaken C
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.